Influenza Disease clinical trials

Explore recruiting influenza disease clinical trials.

Recruiting influenza disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Influenza Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years

France, Finland, Belgium, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Influenza Disease trials by city

Influenza Disease in Toronto Influenza Disease in Vancouver Influenza Disease in Montreal Influenza Disease in Calgary Influenza Disease in Edmonton Influenza Disease in Ottawa Influenza Disease in Winnipeg Influenza Disease in Quebec City Influenza Disease in Hamilton Influenza Disease in Kitchener Influenza Disease in London Influenza Disease in Halifax Influenza Disease in New York Influenza Disease in Los Angeles Influenza Disease in Chicago Influenza Disease in Houston

Influenza Disease clinical trials

Recruiting influenza disease studies right now

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Bone Marrow and Peripheral Blood Immune Responses Study

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

Immune Defense Protein Impact On Respiratory Immune Outcomes

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

Study of Immune Responses to Influenza Vaccination

Also recruiting in Europe

Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years

Influenza Disease trials by city

Other conditions